Author

Iris Rose Peeters

Observed name: I.R. Peeters

Institution: Sint Maartenskliniek

Observed institutions: Radboud University Nijmegen, Radboud University Medical Center, Sint Maartenskliniek, Sint Maartenskliniek, Radboud Institute for Health Sciences

ORCID: 0000-0002-7991-6112

Observed ORCID: 0000-0002-7991-6112

OpenAlex ID: A5073502893

A treat-to-target strategy versus symptom-driven management of gout in the Netherlands (GO TEST Overture): a multicentre, open-label, pragmatic, superiority, randomised controlled trial

2026 · Anusha Moses, Martijn A H Oude Voshaar, et al. · The Lancet Rheumatology · 11

Urate-lowering therapy following a treat-to-target continuation strategy compared to a treat-to-avoid-symptoms discontinuation strategy in gout patients in remission (GO TEST Finale): study protocol of a multicentre pragmatic randomized superiority trial

2023 · Iris Rose Peeters, Alfons A. den Broeder, et al. · Trials · 6

Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study

2025 · Iris Rose Peeters, Maike H M Wientjes, et al. · European Journal of Preventive Cardiology · 5

Perspective of Dutch Patients with Gout on Continuation or Discontinuation of Urate‐Lowering Therapy During Remission: A Mixed‐Methods Study

2024 · Iris Rose Peeters, Frouwke Veenstra, et al. · Arthritis Care & Research · 4

Pos1331 Allopurinol Associated Cardiovascular Risk and Protective Effect of Colchicine in Gout Patients: a Dutch Nationwide Pharmaco-epidemiologic Cohort Study

2025 · I.R. Peeters, M.H.M. Wientjes, et al. · Annals of the Rheumatic Diseases

Anti-citrullinated protein antibody detection by hemagglutination

2024 · Ilmar Kruis, Jyoti Kumari, et al. · Rheumatology Advances in Practice

[Gout: an overview of diagnostics and treatment].

2022 · Iris Rose Peeters, A Martijn H Oude Voshaar, et al. · PubMed

Works count: 7

Citation count: 26

H-index: 4

I10-index: 1